Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/19874312

Download in:

View as

General Info

PMID
19874312